Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02813980 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Neural Circulatory Control and SUDEP Risk.

Name: Neural Circulatory Control and SUDEP Risk. — clinical trial record (NCT02813980)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: NC-SUDEP

StatusActive, Not Recruiting

PhaseNot specified

SponsorMayo Clinic

Started2016-06

View on ClinicalTrials.gov ↗

The investigators believe epilepsy alters the way the body controls blood pressure, heart rate and breathing, and these changes increase the risk of sudden unexpected death in patients with epilepsy (SUDEP). SUDEP-7 is a risk scoring tool which may correlate with these changes to the heart and blood vessels. This research study measures those differences which may help identify new markers to help predict those patients at greatest risk in the future.

Amendment history 2 changes detected by DataLookout

2026-09-12

Primary completion pushed: 2030-12 → 2031-12

2026-09-12

Completion pushed: 2030-12 → 2031-12

Trial Details

NCT Number	NCT02813980
Lead Sponsor	Mayo Clinic Collaborators: American Heart Association
Conditions	Epilepsy, Seizures
Enrollment	39 participants
Start Date	2016-06
Primary Completion	2031-12 (estimated)
Study Completion	2031-12 (estimated)
Updated on ClinicalTrials.gov	2026-09-11